These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2864003)

  • 1. Somatostatin and peripheral blood flow in man.
    Savi L; Cardillo C; Bombardieri G
    Angiology; 1985 Aug; 36(8):511-5. PubMed ID: 2864003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of somatostatin on peripheral circulation. Preliminary study].
    Savi L; Cardillo C; Melina D; Guerrera G; Musumeci V
    J Mal Vasc; 1987; 12(2):175-8. PubMed ID: 2884269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
    Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dosage dependence of the effect of somatostatin on human splanchnic blood flow].
    Keller U; Sonnenberg GE; Kayasseh L; Gyr K; Perruchoud A
    Schweiz Med Wochenschr; 1979 Apr; 109(16):595-6. PubMed ID: 432587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical impedance plethysmography of rheography.
    HERRMANN GR; UZSOY NK; HARRELL WL
    Tex State J Med; 1962 Oct; 58():821-7. PubMed ID: 13954093
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between somatostatin-28 and somatostatin-14 with respect to their biological effects in healthy humans and acromegalics.
    Hadjidakis DJ; Raptis SA; Souvatzoglou A; Karaiskos C; Diamantopoulos EJ; Moulopoulos SD
    Clin Physiol Biochem; 1986; 4(6):372-83. PubMed ID: 2880690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impedance plethysmography in study of the functional reserve of arteriopathic patients].
    Andreozzi GM; Signorelli S; Magnano V; Tornetta D; Ferrara M; Sorrentino F
    Minerva Cardioangiol; 1981 Nov; 29(11):623-30. PubMed ID: 7329566
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EVALUATION OF SEGMENTAL BLOOD FLOW AT THE LEVEL OF THE EXTREMITIES BY RHEOGRAPHY].
    MERLEN JF; COGET J
    Angeiologie; 1965; 17():23-4. PubMed ID: 14303308
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Somatostatin on TSH levels in non-toxic sporadic goiter.
    Varea J; Paredes M; Garces G; Ochoa C; Avila C; Coloma MJ; Briones R; Comaru-Schally AM; Schally AV
    Horm Metab Res; 1990 Dec; 22(12):627-31. PubMed ID: 1981767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion.
    Sieber CC; Beglinger C; Bart S; Tschoepl M; Currie G; Larsen F; Drewe J
    Clin Pharmacol Ther; 2004 Jan; 75(1):70-9. PubMed ID: 14749693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
    Wehrenberg WB; Wiviott SD; Voltz DM; Giustina A
    Endocrinology; 1992 Mar; 130(3):1445-50. PubMed ID: 1347008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
    Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strain-gauge plethysmography in evaluation of the arterial circulation of the limbs. Note I. Study of blood flow at rest in normal and arteriopathic subjects].
    Forconi S; Guerrini M; Vittoria A
    Boll Soc Ital Cardiol; 1975; 20(3):259-65. PubMed ID: 1231815
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin-28 inhibits thyroid-stimulating hormone release in man.
    Klaff LJ; Barron JL; Levitt NS; Ling N; Millar RP
    S Afr Med J; 1982 Dec; 62(25):929-30. PubMed ID: 6128803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of endogenous somatostatin upon human thyrotrophin (TSH) secretion.
    Hickman PE
    Horm Metab Res; 1992 Feb; 24(2):73-7. PubMed ID: 1349294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin and somatostatin receptors in fish growth.
    Sheridan MA; Hagemeister AL
    Gen Comp Endocrinol; 2010 Jul; 167(3):360-5. PubMed ID: 19735661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.